Davis Polk and Homburger advised ADC Therapeutics, while Cooley and Lenz & Staehelin advised the underwriter. ADC Therapeutics SA announced a registered secondary offering of 12,000,000...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell represented Roivant Sciences, while Latham & Watkins represented the underwriters in the offering. Roivant Sciences (Nasdaq: ROIV) has announced its $230 million...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Pacific Biosciences of California on the offering, and Davis Polk advised the representatives of the several underwriters involved. Pacific Biosciences of California Inc. announced...
You must be a Standard 1 Year member to access this content.
O’Melveny & Myers LLP served as Semtech U.S. legal counsel and Stikeman Elliott LLP as its Canadian legal counsel. Davis Polk & Wardwell LLP served as...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Sirio Pharma Co. Ltd. on the deal. Sirio Pharma announced the acquisition of a majority stake of Best Formulations, as part of its strategy to...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Morgan Stanley, the representative of the several underwriters in the transaction. The transaction consisted of a $700 million SEC-registered offering of 5,923,670 common shares...
You must be a Standard 1 Year member to access this content.
Davis Polk and BKM advised Telefónica Celular del Paraguay on the transaction. Telefónica Celular del Paraguay S.A.E. (TELECEL) announced its cash tender offer to purchase for...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Privia Health Group on the offering, while Goodwin Procter advised the underwriters. Privia Health Group, Inc. announced the establishment of a WKSI shelf and...
You must be a Standard 1 Year member to access this content.
Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. RAPT Therapeutics, Inc. executed a $75 million SEC-registered follow-on offering of 4,054,055...
You must be a Standard 1 Year member to access this content.
Davis Polk advised KOITO MANUFACTURING on the deal. KOITO MANUFACTURING CO., LTD. announced its $100 million strategic investment in newly issued convertible preferred stock of Cepton,...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Roivant Sciences Ltd. in the deal, while Covington represented the underwriter, Cantor Fitzgerald. Roivant Sciences Ltd. announced its debut SEC-registered offering of 30,000,000...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented VillageMD in the transaction, Cleary Gottlieb and McDermott Will & Emery represented Summit Health-CityMD, while Wachtell, Lipton, Rosen & Katz served as legal...
You must be a Standard 1 Year member to access this content.
